Anti-BCMA CAR T cell therapy for multiple myeloma

Bookmark and Share
Published: 10 Dec 2017
Views: 2104
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA

Dr Kochenderfer presents, in a press conference at the 2017 ASH annual meeting, updated results from a multicenter study of bb2121 anti-BCMA CAR T cell therapy.

Read the news story or watch the interview with Dr Kochenderfer for more.